Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2001 | 07-2001 | 04-2001 | 01-2001 | 10-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,287,700 | -1,110,800 | -1,052,800 | -7,600 | 868,100 |
| Depreciation Amortization | 197,800 | 543,400 | 104,000 | 48,300 | 146,200 |
| Income taxes - deferred | -438,900 | -349,800 | -317,600 | 1,200 | 332,000 |
| Accounts receivable | 339,300 | 243,400 | 181,600 | 83,300 | -158,700 |
| Accounts payable and accrued liabilities | -61,700 | -46,900 | -15,600 | 5,700 | 83,600 |
| Other Working Capital | 128,300 | -40,300 | -152,200 | -186,900 | -122,200 |
| Other Operating Activity | 1,217,900 | 773,100 | 1,193,100 | -37,600 | -898,100 |
| Operating Cash Flow | $95,000 | $12,100 | $-59,500 | $-93,600 | $250,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 165,900 | 59,400 | N/A | N/A |
| PPE Investments | -230,800 | -220,200 | -175,200 | -96,600 | -375,300 |
| Net Acquisitions | 68,800 | -25,100 | -48,700 | -48,700 | -345,300 |
| Purchase Of Investment | -29,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 222,000 | -2,800 | 500 | -7,800 | 196,500 |
| Investing Cash Flow | $31,000 | $-82,200 | $-164,000 | $-153,100 | $-524,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -35,800 | N/A | 91,400 | 168,600 | -32,500 |
| Debt Repayment | N/A | -34,600 | N/A | N/A | N/A |
| Common Stock Issued | 40,400 | 33,900 | 32,700 | 19,000 | 277,200 |
| Financing Cash Flow | $4,600 | $-700 | $124,100 | $187,600 | $244,700 |
| Exchange Rate Effect | 700 | -1,500 | -800 | 100 | -3,700 |
| Beginning Cash Position | 217,300 | 217,300 | 217,300 | 217,300 | 279,000 |
| End Cash Position | 348,600 | 145,000 | 117,100 | 158,300 | 217,300 |
| Net Cash Flow | $131,300 | $-72,300 | $-100,200 | $-59,000 | $-61,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 95,000 | 12,100 | -59,500 | -93,600 | 250,900 |
| Capital Expenditure | -249,200 | -220,200 | -175,200 | -96,600 | -375,300 |
| Free Cash Flow | -154,200 | -208,100 | -234,700 | -190,200 | -124,400 |